BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35154108)

  • 21. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.
    Verhagen MM; Last JI; Hogervorst FB; Smeets DF; Roeleveld N; Verheijen F; Catsman-Berrevoets CE; Wulffraat NM; Cobben JM; Hiel J; Brunt ER; Peeters EA; Gómez Garcia EB; van der Knaap MS; Lincke CR; Laan LA; Tijssen MA; van Rijn MA; Majoor-Krakauer D; Visser M; van 't Veer LJ; Kleijer WJ; van de Warrenburg BP; Warris A; de Groot IJ; de Groot R; Broeks A; Preijers F; Kremer BH; Weemaes CM; Taylor MA; van Deuren M; Willemsen MA
    Hum Mutat; 2012 Mar; 33(3):561-71. PubMed ID: 22213089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype-phenotype relationships in ataxia-telangiectasia and variants.
    Gilad S; Chessa L; Khosravi R; Russell P; Galanty Y; Piane M; Gatti RA; Jorgensen TJ; Shiloh Y; Bar-Shira A
    Am J Hum Genet; 1998 Mar; 62(3):551-61. PubMed ID: 9497252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ataxia telangiectasia: a review.
    Rothblum-Oviatt C; Wright J; Lefton-Greif MA; McGrath-Morrow SA; Crawford TO; Lederman HM
    Orphanet J Rare Dis; 2016 Nov; 11(1):159. PubMed ID: 27884168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA sequencing combining with whole exome sequencing reveals a compound heterozygous variant in ATM in a girl with atypical ataxia-telangiectasia.
    Gu C; Wang H; Shu J; Zheng J; Li D; Cai C; Zhang P
    Clin Chim Acta; 2021 Dec; 523():6-9. PubMed ID: 34453918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trajectories of motor abnormalities in milder phenotypes of ataxia telangiectasia.
    van Os NJH; Hensiek A; van Gaalen J; Taylor AMR; van Deuren M; Weemaes CMR; Willemsen MAAP; van de Warrenburg BPC
    Neurology; 2019 Jan; 92(1):e19-e29. PubMed ID: 30504431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ataxia-telangiectasia: Immunodeficiency and survival.
    van Os NJH; Jansen AFM; van Deuren M; Haraldsson A; van Driel NTM; Etzioni A; van der Flier M; Haaxma CA; Morio T; Rawat A; Schoenaker MHD; Soresina A; Taylor AMR; van de Warrenburg BPC; Weemaes CMR; Roeleveld N; Willemsen MAAP
    Clin Immunol; 2017 May; 178():45-55. PubMed ID: 28126470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.
    Staples ER; McDermott EM; Reiman A; Byrd PJ; Ritchie S; Taylor AM; Davies EG
    Clin Exp Immunol; 2008 Aug; 153(2):214-20. PubMed ID: 18505428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different clinical and immunological presentation of ataxia-telangiectasia within the same family.
    Soresina A; Meini A; Lougaris V; Cattaneo G; Pellegrino S; Piane M; Darra F; Plebani A
    Neuropediatrics; 2008 Feb; 39(1):43-5. PubMed ID: 18504682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New diagnosis of atypical ataxia-telangiectasia in a 17-year-old boy with T-cell acute lymphoblastic leukemia and a novel ATM mutation.
    Roohi J; Crowe J; Loredan D; Anyane-Yeboa K; Mansukhani MM; Omesi L; Levine J; Revah Politi A; Zha S
    J Hum Genet; 2017 Apr; 62(5):581-584. PubMed ID: 28123174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network.
    Cirillo E; Polizzi A; Soresina A; Prencipe R; Giardino G; Cancrini C; Finocchi A; Rivalta B; Dellepiane RM; Baselli LA; Montin D; Trizzino A; Consolini R; Azzari C; Ricci S; Lodi L; Quinti I; Milito C; Leonardi L; Duse M; Carrabba M; Fabio G; Bertolini P; Coccia P; D'Alba I; Pession A; Conti F; Zecca M; Lunardi C; Bianco ML; Presti S; Sciuto L; Micheli R; Bruzzese D; Lougaris V; Badolato R; Plebani A; Chessa L; Pignata C
    J Clin Immunol; 2022 May; 42(4):783-797. PubMed ID: 35257272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective Diagnosis of Ataxia-Telangiectasia in an Adolescent Patient With a Remote History of T-Cell Leukemia.
    Sze SK; Lederman HM; Crawford TO; Wangler MF; Lewis AM; Kastan MB; Dibra HK; Taylor AMR; Wechsler DS
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e138-e140. PubMed ID: 31743320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ataxia-telangiectasia in the south of Tunisia: A study of 11 cases.
    Sfaihi L; Stoppa Lyonnet D; Ben Ameur S; Dubois D'enghien C; Kamoun T; Barbouch MR; Hachicha M
    Tunis Med; 2015; 93(8-9):511-5. PubMed ID: 26815515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with ataxia-telangiectasia?
    Azarsiz E; Karaca NE; Gunaydin NC; Gulez N; Ozturk C; Aksu G; Genel F; Kutukculer N
    Int J Immunopathol Pharmacol; 2014; 27(3):421-7. PubMed ID: 25280033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ataxia telangiectasia syndrome: moonlighting ATM.
    Zaki-Dizaji M; Akrami SM; Abolhassani H; Rezaei N; Aghamohammadi A
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1155-1172. PubMed ID: 29034753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three new cases of ataxia-telangiectasia-like disorder: No impairment of the ATM pathway, but S-phase checkpoint defect.
    Fiévet A; Bellanger D; Valence S; Mobuchon L; Afenjar A; Giuliano F; Dubois d'Enghien C; Parfait B; Pedespan JM; Auger N; Rieunier G; Collet A; Burglen L; Stoppa-Lyonnet D; Stern MH
    Hum Mutat; 2019 Oct; 40(10):1690-1699. PubMed ID: 31033087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel variant in ATM gene causes ataxia telangiectasia revealed by whole-exome sequencing.
    Alonazi NA; Hundallah KJ; Al Hashem AM; Mohamed S
    Neurosciences (Riyadh); 2018 Apr; 23(2):162-164. PubMed ID: 29664460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of mutations in ATM, the gene responsible for ataxia telangiectasia in patients with cerebellar ataxia.
    Hassin-Baer S; Bar-Shira A; Gilad S; Galanty Y; Khosravi R; Lossos A; Giladi N; Weitz R; Ben-Zeev B; Goldhammer Y; Shiloh Y
    J Neurol; 1999 Aug; 246(8):716-9. PubMed ID: 10460451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ataxia-telangiectasia, an evolving phenotype.
    Chun HH; Gatti RA
    DNA Repair (Amst); 2004; 3(8-9):1187-96. PubMed ID: 15279807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration.
    Lavin MF
    DNA Repair (Amst); 2013 Aug; 12(8):612-9. PubMed ID: 23731731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel pathogenic variant in an Iranian Ataxia telangiectasia family revealed by next-generation sequencing followed by in silico analysis.
    Tabatabaiefar MA; Alipour P; Pourahmadiyan A; Fattahi N; Shariati L; Golchin N; Mohammadi-Asl J
    J Neurol Sci; 2017 Aug; 379():212-216. PubMed ID: 28716242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.